Crewe Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$221K Hold
8,322
0.03% 143
2025
Q1
$201K Hold
8,322
0.03% 134
2024
Q4
$335K Sell
8,322
-8,044
-49% -$324K 0.05% 108
2024
Q3
$1.04M Buy
+16,366
New +$1.04M 0.12% 54